Her rheumatologist instructed her to undergo a baseline ocular examination prior to initiating Plaquenil (hydroxychloroquine, Sanofi-Aventis) therapy. Toxic maculopathy associated with chloroquine use was first documented in the literature five decades ago.1 In the United States, Plaquenil––an analog to chloroquine––is used to treat a variety of conditions, including rheumatoid arthritis, lupus and several distinct inflammatory disorders. Although the incidence of macular toxicity is infrequent with Plaquenil use (at a dosage of 200mg or 400mg q.d.), its visual impact can be devastating. Hydroxychloroquine originally used to treat Visual fields in chloroquine Chloroquine injection dosage Eye exam / Plaquenil. Support Forums. Was the doc saying after taking it for 5 years that the risk is likely of having eye problems? Some say toxicity is rare, and only occurs mainly in people taking too high of a dose. But then you read alot of people having problems, and looks like the eye problems isn't so rare. Plaquenil Eye Exams. Plaquenil, also known as hydroxychloroquine, is a medication used in the treatment or prevention of malaria. It has also been used to treat other conditions, such as liver disease, that may have been caused by the same parasites that cause malaria. Plaquenil has also been used to treat the symptoms of arthritis. Wrong Hydroxychloroquine Dose Is Common, Putting Eyes at Risk Up to half of patients treated with the arthritis drug hydroxychloroquine Plaquenil are prescribed more than the recommended maximum amount, according to new research. Initially, central visual acuity may be unaffected, but the patient may notice related paracentral scotomas that often interfere with reading. The associated classic retinal toxicity is described as a bull’s eye maculopathy (ring of depigmented retinal pigment epithelium that spares the foveal area). Hydroxychloroquine toxicity eye exam Plaquenil Side Effects on Your Eyes and Vision, Plaquenil Eye Exams - Catalina Eye Care Diphenhydramine interaction with plaquenil Hydroxychloroquine And Chloroquine Screening 2016 AAO Recommendations The American Academy of Ophthalmology released an updated set of screening recommendations for hydroxychloroquine Plaquenil and chloroquine to account for the many studies that have shown the effects of these medications on the retina 1. Hydroxychloroquine And Chloroquine Screening 2016 AAO.. Wrong Hydroxychloroquine Dose Is Common, Putting Eyes at Risk.. Retinal toxicity associated with chronic exposure to.. Macular Society Eye screening for patients taking hydroxychloroquine. Hydroxychloroquine is a medication used to treat several conditions including rheumatoid arthritis, systemic lupus erythematosus, some skin conditions especially photosensitive ones and others that involve inflammation. Remember, any patient who is at a high risk for Plaquenil toxicity should be examined on an annual basis following the baseline exam. The goal of monitoring/screening is to identify early macular damage prior to irreversible vision loss or even before visible signs of bull’s eye maculopathy. Of course the aim is avoid drug related retinal toxicity, which on ophthalmic examination, appears as the classic Bull’s eye change affecting the macula. Once retinal toxicity from hydroxychloroquine occurs, it is thought that the retinal changes are permanent and the disease can progress even if hydroxychloroquine is stopped for 1 to 3 years.